Trademark: 85277030
Word
INSTATAB
Status
Dead
Status Code
606
Status Date
Monday, June 3, 2013
Serial Number
85277030
Mark Type
4000
Filing Date
Friday, March 25, 2011
Published for Opposition
Tuesday, September 4, 2012
Abandoned Date
Monday, June 3, 2013

Trademark Owner History
Valeant International (Barbados) SRL - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions
Color is not claimed as a feature of the mark.

Trademark Events
Jan 21, 2015
Assignment Of Ownership Not Updated Automatically
Jan 22, 2014
Attorney Revoked And/Or Appointed
Jan 22, 2014
Teas Revoke/Appoint Attorney Received
Jun 3, 2013
Abandonment Notice Mailed - No Use Statement Filed
Jun 3, 2013
Abandonment - No Use Statement Filed
Oct 30, 2012
Noa E-Mailed - Sou Required From Applicant
Sep 4, 2012
Official Gazette Publication Confirmation E-Mailed
Sep 4, 2012
Published For Opposition
Aug 15, 2012
Notification Of Notice Of Publication E-Mailed
Jul 31, 2012
Law Office Publication Review Completed
Jul 31, 2012
Approved For Pub - Principal Register
Jul 31, 2012
Examiner's Amendment Entered
Jul 30, 2012
Notification Of Examiners Amendment E-Mailed
Jul 30, 2012
Examiners Amendment E-Mailed
Jul 30, 2012
Examiners Amendment -Written
Jan 1, 2012
Notification Of Final Refusal Emailed
Jan 1, 2012
Final Refusal E-Mailed
Jan 1, 2012
Final Refusal Written
Dec 16, 2011
Teas/Email Correspondence Entered
Dec 16, 2011
Correspondence Received In Law Office
Dec 16, 2011
Assigned To Lie
Dec 14, 2011
Teas Response To Office Action Received
Jun 14, 2011
Notification Of Non-Final Action E-Mailed
Jun 14, 2011
Non-Final Action E-Mailed
Jun 14, 2011
Non-Final Action Written
Jun 9, 2011
Assigned To Examiner
Mar 29, 2011
New Application Office Supplied Data Entered In Tram
Mar 29, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24